Winthrop Opens LI's Only Hypertrophic Cardiomyopathy Center


Vol. 17, No. 3
Fall 2007

  • The Institute for Neurosciences: At the Vanguard of Specialized Care

  • Nine Winthrop Specialists Named to New York Magazine's “Best Doctors List

  • Good Health - It's in Our Hands

  • Tuskegee Airman Regains the Gift of Sight

  • Stroke Care at Winthrop

  • Under the Big Top

  • Golfing for the Kids

  • Pat Lyons Foundation Shows Unwavering Support for Generation of Survivors Program

  • Winthrop Opens LI's Only Hypertrophic Cardiomyopathy Center

  • Migliozzi Family Donates Rocking Chair to NICU

  • Jay's World Foundation Shows Ongoing Support

  • Winthrop's Home Health Agency Tops National List Again

  • Clinical Trials: Bringing the Future of Medicine to Long Island

  • 2007 MineolaStreet Fair

    Back to Publications

  • Long Island's first and only comprehensive Hypertrophic Cardiomyopathy (HCM) Center has opened at Winthrop-University Hospital.

    The most common cause of heartrelated sudden death in people under 30, HCM is a well-recognized cause of heart failure, chest pain, shortness of breath and premature death in adults. The condition is characterized by excessive thickening of the heart muscle, which makes it difficult for the heart to pump blood effectively. This can result in shortness of breath, lightheadedness, palpitations and even heart failure. In rare instances, it can lead to sudden collapse and even death during or following rigorous exercise.

    Under the expert leadership of Srihari S. Naidu, MD, Director of Winthrop's Cardiac Catheterization Center, and well known as a clinician and researcher in the field of interventional cardiology, Winthrop's new HCM Center offers comprehensive, expert care for HCM patients. Treatment options include:

    • Screening and Diagnosis
    • Genetic Counseling / Screening
    • Electrophysiologic Testing
    • Lifestyle Modification Counseling
    • Medical Therapy
    • Permanent Pacemaker
    • Alcohol Septal Ablation (ASA)
    • Surgical Myectomy (open-heart surgery)
    • Implantable Defibrillator (ICD)


    Over the past year, Dr. Naidu has initiated the use of alcohol septal ablation at Winthrop. "It is an effective, minimally invasive treatment technique for qualified HCM patients in whom medical therapy has failed," he said. "The procedure provides a less invasive alternative to open-heart surgery and involves the controlled injection of a small amount of absolute alcohol into the heart to destroy excessive heart muscle in the septum. We have had great success with it in appropriate patients."

    Before joining Winthrop, Dr. Naidu introduced the technique at New York Presbyterian Hospital Ð Cornell Medical Center. Dr. Naidu has also developed modifications to the procedure, which have been published in prestigious peer-reviewed medical journals. Now at Winthrop, Dr. Naidu is frequently asked to lecture on and teach the procedure both locally and nationally, and is a regularly invited speaker at the American Heart Association and American College of Cardiology annual scientific sessions.

    A component of Winthrop's Division of Cardiology and the Hospital's Institute for Heart Care, the HCM Center has been named a Center of Excellence by the national Hypertrophic Cardiomyopathy Association (HCMA). In November, Winthrop and the HCMA will co-sponsor Long Island's first HCM Symposium, which will be open to patients, their families and healthcare providers.

    For information about Winthrop's Hypertrophic Cardiomyopathy Center, call (516) 663-9696.



    [ Home | Search | Contact | Directions | Privacy Notice ]

    Winthrop-University Hospital | 259 First Street | Mineola NY 11501 | 516-663-0333

    This site provides information as a resource. It is not a substitute for professional medical advice.
    Always consult a physician or healthcare provider for treatment and guidance toward good health.
    Copyright © 2008 Winthrop-University Hospital. All rights reserved. Long Island Web Design